References
- Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K, et al.. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia. 1997;11:1447–52.
- Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, et al.. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358:1909–18.
- Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al.. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
- Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, et al.. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.
- Grimwade D. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Pract Res Clin Haematol. 2001;14:497–529.
- Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev. 2004;18:115–36.
- Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, et al.. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363:2424–33.
- Yan XJ, Xu J, Gu ZH, Pan CM, Lu G, Shen Y, et al.. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43:309–15.
- Thol F, Damm F, Ludeking A, Winschel C, Wagner K, Morgan M, et al.. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol. 2011;29:2889–96.
- Green CL, Evans CM, Zhao L, Hills RK, Burnett AK, Linch DC, et al.. The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. Blood. 2011;118:409–12.
- Patel J, Abdel-Wahab O, Gonen M, Figueroa ME, Fernandez HF, Sun Z, et al.. High-throughput mutational profiling in AML: mutational analysis of the ECOG E1900 Trial (Abstract). Blood. 2010;116(21):370–1.
- Green CL, Evans CM, Hills RK, Burnett AK, Linch DC, Gale RE, et al.. The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status. Blood. 2010;116:2779–82.
- Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al.. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18:553–567.
- Chou WC, Chou SC, Liu CY, Chen CY, Hou HA, Kuo YY, et al.. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood. 2011;118:3803–10.
- Metzeler K, Maharry K, Radmacher MD, Mrózek K, Margeson D, Becker H, et al.. Mutations In the Tet Oncogene Family Member 2 (TET2) gene refine the new European LeukemiaNet risk classification of primary, cytogenetically normal acute myeloid leukemia (CN-AML) in adults: a cancer and leukemia group B (CALGB) study (ABSTRACT). Blood. 2010;116.
- Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N, et al.. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2009;145:788–800.
- Abdel-Wahab O, Kilpivaara O, Patel J, Busque L, Levine RL. The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration. Leukemia. 2010;24:1656–7.
- Metzeler KH, Becker H, Maharry K, Radmacher MD, Kohlschmidt J, Mrózek K, et al.. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN ‘favorable’ genetic category. Blood. 2011;118(26):6920–9.
- Pratcorona M, Abbas S, Sanders M, Koenders J, Kavelaars F, Erpelinck-Verschueren C, et al.. Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value. Haematologica. 2011 Nov 4. [Epub ahead of print]
- Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, et al.. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010;42:338–42.
- Van Vlierberghe P, Patel J, Abdel-Wahab O, Lobry C, Hedvat CV, Balbin M, et al.. PHF6 mutations in adult acute myeloid leukemia. Leukemia. 2011;25:130–4.